(4-015) Incidence of Alteplase Utilization for Central Venous Access De-clotting in Patients with Active COVID-19

Monday, December 5, 2022

2:00 PM – 3:30 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Clinical Topics/Therapeutics

Co-Author(s): Karen Lindell

Primary Author(s)

Andrew Kessell, PharmD, MBA, MS
Director, Clinical Pharmacy Services / PGY-1 Residency Program Director
FirstHealth Moore Regional Hospital, North Carolina